Elvina Almuradova

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Elvina Almuradova
Mar 22, 2025, 07:26 | Science
Elvina Almuradova: Cemiplimab monotherapy vs chemotherapy as a first-line treatment with advanced NSCLC with PD-L1 expression
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Mar 15, 2025, 08:34 | Science
Elvina Almuradova: Longer duration of ICI therapy linked to higher complete response rates in MMRd cancers
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 12, 2025, 06:58 | Blog
Elvina Almuradova: CtDNA-guided approach for ACT in stage II colon cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 11, 2025, 07:33 | Blog
Elvina Almuradova: 177 Lu-edotreotide vs everolimus in GEP-NETs
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 6, 2025, 18:06 | Science
Elvina Almuradova: Chemotherapy-induced neuropathy is still one of the biggest problems reducing patients’ QOL
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 4, 2025, 11:18 | Blog
Elvina Almuradova: ENHERTU Brings New Hope for Gastric Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Mar 1, 2025, 15:12 | Science
Elvina Almuradova: Exercise and Colon Cancer Survival
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Feb 28, 2025, 14:50 | Blog
Elvina Almuradova: The FDA has granted fast track designation to 67Cu-SAR-bisPSMA for PSMA-positive mCRPC
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Feb 27, 2025, 09:08 | Science
Elvina Almuradova: A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Feb 26, 2025, 10:59 | Science
Elvina Almuradova: How GEMSTONE-303 differs from other trials
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Feb 24, 2025, 09:10 | Blog
Elvina Almuradova: What was once a disease measured in months is now measured in years
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Feb 22, 2025, 13:28 | Science
Elvina Almuradova: Immunotherapy for HPV-Associated Cancers
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared an article…
Feb 17, 2025, 09:10 | Science
Elvina Almuradova: Can yogurt lower colon cancer risk?
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Feb 17, 2025, 08:32 | Science
Elvina Almuradova: New Blood Test for Early Pancreatic Cancer Detection
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Feb 12, 2025, 14:22 | Blog
Elvina Almuradova: Happy Women in Science Day
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: "Happy…
Feb 9, 2025, 15:15 | Science
Elvina Almuradova: Survival outcomes for ERBB2-positive MBC patients with brain metastases
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared an…
Feb 8, 2025, 13:29 | Blog
Elvina Almuradova: FIRE-4 Trial Confirms the Clinical Relevance of Liquid Biopsy in mCRC
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: "FIRE-4…
Feb 6, 2025, 15:08 | Insight
Elvina Almuradova: International treatment guidelines vs. national reimbursement policies in Turkey
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn about…
Feb 5, 2025, 07:02 | Blog
Assessment of Predisposition Genes in High-Grade Serous Ovarian Carcinoma via Germline and Tumour Sequencing
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on X: "New study…
Feb 5, 2025, 00:00 | Science
Elvina Almuradova: PTC significantly prolongs OS in patients with HER2+ metastatic breast cancer
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn about…
Feb 4, 2025, 08:25 | Blog
Perioperative chemo (FLOT) outperforms preop chemoradiotherapy for resectable esophageal adenocarcinoma
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared an article by Jens Hoeppner, et…
Jan 31, 2025, 07:20 | Blog
Elvina Almuradova: Pertuzumab + trastuzumab retreatment to prolong OS in HER2+ metastatic breast cancer
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on X: "PRECIOUS study:…
Jan 28, 2025, 08:26 | Blog
Elvina Almuradova: Promising results with Daraxonrasib in RAS-mutant PDAC
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, posted the following on LinkedIn: “Daraxonrasib (RMC-6236), an…
Jan 27, 2025, 16:50 | Blog
Elvina Almuradova: Promising First-Line Treatment for BRAF V600E-Mutant mCRC
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: "BREAKWATER…
Jan 27, 2025, 08:54 | Blog
GISTs with PDGFRA mutation show lower 18F-FDG uptake compared to other molecular subtypes
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared an article…
Jan 26, 2025, 07:32 | Blog
Elvina Almuradova: Waist circumference and waist-to-hip ratio as predictors of colorectal cancer risk
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, posted on X about recent paper…
Jan 25, 2025, 12:41 | Insight
Elvina Almuradova: Targeting c-MET overexpression is reshaping EGFR-mutant NSCLC treatment
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on X: “Breaking News from…
Jan 23, 2025, 14:33 | Blog
Elvina Almuradova: Improving Cancer Outcomes and Leadership Course
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: "Improving…
Jan 22, 2025, 13:56 | Blog
Elvina Almuradova: Obesity and Colorectal Cancer - New Research Insights
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: “Obesity…
Jan 18, 2025, 14:02 | Blog
Elvina Almuradova: CDK4/6 inhibitor + ET as first-line standard for HR+ mBC
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn: "A…
Jan 17, 2025, 22:36 | Blog
Elvina Almuradova: FDA has granted Fast Track designation to LOAd703 for pancreatic cancer
Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on X: "FDA…
Jan 16, 2025, 15:49 | Insight
Elvina Almuradova: Delighted to continue serving as a ESO Ambassador for Turkey
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jan 14, 2025, 06:22 | Insight
Elvina Almuradova: The British Sarcoma Group has released updated clinical practice guidelines on GISTs
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jan 13, 2025, 12:36 | Science
Elvina Almuradova: Effect of KRAS mutations on survival outcomes in metastatic pancreatic cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, posted on LinkedIn…
Jan 12, 2025, 07:07 | Insight
Elvina Almuradova: ctDNA/MRD testing shows promise in guiding colon cancer treatment
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology, shared a post…
Jan 9, 2025, 15:50 | Blog
Elvina Almuradova: Dual-HER2 inhibition with trastuzumab + pertuzumab in HER2-positive mCRC
Elvina Almuradova, Associate Professor of Oncology at IEO (European Institute of Oncology) shared on LinkedIn:…
Jan 8, 2025, 11:53 | Blog
Elvina Almuradova: Urgent efforts to address the rising rates of early-onset colorectal cancer
Elvina Almuradova, Associate Professor of Oncology at IEO (European Institute of Oncology), shared on LinkedIn: "A…
Jan 6, 2025, 09:37 | Blog
Elvina Almuradova: A causal link between alcohol consumption and an increased risk of cancer
Elvina Almuradova, Associate Professor of Oncology at IEO (European Institute of Oncology), shared a post…
Jan 5, 2025, 16:41 | Blog
Elvina Almuradova: This is the Map Showing the Frequency of Cervical Cancer
Elvina Almuradova, Associate Professor of Oncology at IEO (European Institute of Oncology), shared a post…
Jan 3, 2025, 15:18 | Blog
Elvina Almuradova: January is Cervical Cancer Awareness Month
Elvina Almuradova, Associate Professor of Oncology at IEO (European Institute of Oncology), shared a post…
Jan 2, 2025, 15:20 | Blog
Elvina Almuradova: A New Era in Cancer Treatment - FDA Approves Subcutaneous Nivolumab
Elvina Almuradova, Associate Professor of Oncology at IEO Istituto Europeo di Oncologia, shared a post…
Dec 28, 2024, 14:09 | Science
The new NCCN guidelines for immunotherapy-related toxicities
Elvina Almuradova, Associate Professor and Medical Oncologist Ambassador at European School of Oncology, shared a…
Dec 28, 2024, 11:40 | Science
Elvina Almuradova: Tislelizumab-jsgr with chemotherapy as a first-line treatment for metastatic HER2-negative GEJ adenocarcinoma
Elvina Almuradova, Associate Professor at Medicana Health Group, posted on LinkedIn: "The FDA has approved…
Dec 27, 2024, 01:25 | Blog
IASO presents Mastery of Surgery - IASO Academics
IASO Academics shared a post on X: "IASO presents Mastery of Surgery. Chapter 1 Tuesday,…
Dec 24, 2024, 18:06 | Blog
Elvina Almuradova: ESPAC4 Long-Term Results in Journal of Clinical Oncology
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: “ESPAC4 Long-Term…
Dec 22, 2024, 05:00 | Blog
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: "Being a…
Dec 20, 2024, 14:04 | Science
Elvina Almuradova: JAVELIN Renal 101 Phase 3 Trial Results by Toni Choueiri et al.
A recent paper by Toni Choueiri, Director of the Lank Center for Genitourinary Oncology at…
Dec 16, 2024, 17:51 | Insight
Best of 2024 SABCS - San Antonio Breast Cancer Symposium
The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…
Dec 15, 2024, 10:54 | Blog
Elvina Almuradova: EMBER-3 trial highlights imlunestrant for metastatic breast cancer
Elvina Almuradova, Associate Professor at Medicana Health Group, posted the following on LinkedIn: “The EMBER-3 trial…
Dec 12, 2024, 13:26 | Insight
Highlights from Day 2 of SABCS 2024
The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…
Nov 24, 2024, 18:03 | Blog
Elvina Almuradova: FDA approves Zanidatama for HER2+ biliary tract cancer
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on X: "FDA approves…
Nov 16, 2024, 09:14 | Blog
Elvina Almuradova: Prevention and Treatment of Cancer-Related Infections by JNCCN
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on X: "Journal of…
Nov 11, 2024, 13:46 | Blog
Elvina Almuradova: Meaningful discussions on lung cancer with some of the foremost researchers in the field
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: "Grateful for…
Nov 9, 2024, 18:33 | Blog
Elvina Almuradova: Proud to be part of the Turkish Oncology Research Workshop
Elvina Almuradova, Associate Professor at Medicana Health Group, shared the following post on LinkedIn: “Proud to…
Nov 6, 2024, 12:26 | Insight
New Hope for Advanced Gastric Cancer
An article by Samuel Klempner, Medical Oncologist at Massachusetts General Hospital, was recently mentioned by…
Oct 23, 2024, 12:18 | Insight
Elvina Almuradova: Reasearch shows radioactive iodine increases skin cancer risk in thyroid cancer patients
Elvina Almuradova, Associate Professor at Medicana Health Group, shared the following post on LinkedIn: “Research…
Oct 5, 2024, 12:03 | Insight
Elvina Almuradova: "Oncofetal ecosystem" in HCC linked to early relapse after surgery
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on X about a…
Sep 29, 2024, 16:20 | Insight
Elvina Almuradova: Using ICis as a first-line treatment may pose a risk of toxicity in unresectable ESCC
Elvina Almuradova, Associate Professor of Oncology at Medicana Sağlık Grubu, shared a post on LinkedIn:…
Sep 21, 2024, 19:35 | Insight
Elvina Almuradova: The NCT03886441 trial
Elvina Almuradova, Associate Professor, Medicana Health Group, shared a post on X: “The NCT03886441 trial,…
Sep 17, 2024, 14:27 | Blog
Elvina Almuradova: Promising results from the NO-CUT trial in pMMR LARC patients
Elvina Almuradova, Associate Professor, Medicana Health Group, shared a post on LinkedIn: "Promising results from the NO-CUT…
Sep 15, 2024, 10:22 | Blog
Elvina Almuradova: DisACcontinuing anti-HER2 treatment in super responders could be considered
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on X: "Discontinuing anti-HER2…
Sep 14, 2024, 19:20 | Insight
Elvina Almuradova: The future treatment landscape for hepatocellular carcinoma looks hopeful
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on X: “ The future…
Sep 14, 2024, 17:49 | Blog
Elvina Almuradova: Great opportunity to learn, network, and be inspired by cutting-edge research
Elvina Almuradova, Ambassador at the European School of Oncology, shared a post on X: "It's…
Sep 7, 2024, 09:28 | Drugs
Elvina Almuradova: Doxorubicin with Trabectedin show promising results for patients with leiomyosarcoma
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared on LinkedIn: "New findings published…
Sep 6, 2024, 14:43 | Insight
Elvina Almuradova: Incorporating exercise as a part of supportive care for BC patients is essential for HRQOL
Elvina Almuradova, Associate Professor, Medicana Health Group, shared a post on LinkedIn: "The multinational PREFERABLE-EFFECT…
Aug 20, 2024, 16:41 | Insight
Elvina Almuradova: Metastasis-free or treatment-free survival
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X about…
Aug 17, 2024, 03:41 | Insight
Burden of 30 cancers among men
Elvina Almuradova, Ambassador at European School of Oncology, shared on LinkedIn a recent paper by…
Aug 14, 2024, 02:22 | Insight
Elvina Almuradova: Increased Breast Cancer Risk in Women with POI
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on LinkedIn:…
Aug 6, 2024, 14:09 | Blog
DeepHRD predicts HRD from routine biopsy slides
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X,…
May 23, 2024, 01:52 | Blog
Don't miss the dedicated ESCO e-session on Maximizing the benefits of a Fellowship - European School of Oncology
European School of Oncology shared on LinkedIn: "Appointment for your agendas: 28 May, 18:15 CET Don't…
All: 70 Posts: 1 - 100
Special Coverage